Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models.

Autor: Horn, Lucas A.1 (AUTHOR), Lind, Hanne1 (AUTHOR), Fousek, Kristen1 (AUTHOR), Qin, Haiyan1 (AUTHOR), Rajabian, Nika1 (AUTHOR), Angstadt, Shantel1 (AUTHOR), Hsiao-Sanchez, Nicole1 (AUTHOR), Medina-Enriquez, Miriam M.1 (AUTHOR), Kelly, Marcus D.1 (AUTHOR), Allen, Clint T.2 (AUTHOR), Hammoudeh, Sarah M.3 (AUTHOR), Weigert, Roberto3 (AUTHOR), Maeda, Dean Y.4 (AUTHOR), Zebala, John A.4 (AUTHOR), Palena, Claudia1 (AUTHOR) palenac@mail.nih.gov
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 12/5/2024, Vol. 43 Issue 1, p1-22. 22p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje